YOSHIHIRO YONEKAWA, M.D.
Ophthalmology Physician · PLYMOUTH MEETING, PA
Individual Active NPI 1962727008
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,524 | 57,880 | $28,311,358 | $8,855,044 | $6,991,340 |
| 2023 | 1,557 | 44,230 | $25,154,799 | $8,154,814 | $6,429,308 |
| 2022 | 1,654 | 27,462 | $19,797,059 | $6,506,463 | $5,136,580 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 17,160 | $34 | $27 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 12,877 | $227 | $181 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 5,910 | $147 | $117 |
| 92134 | Imaging of retina | 5,487 | $42 | $31 |
| 67028 | Injection of drug into eye | 3,923 | $135 | $104 |
| 92012 | Established patient problem focused exam of visual system | 2,971 | $93 | $69 |
| J0178 | Injection, aflibercept, 1 mg | 2,786 | $818 | $652 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 2,780 | $108 | $86 |
| J3299 | Injection, triamcinolone acetonide (xipere), 1 mg | 1,368 | $48 | $38 |
| 92014 | Established patient complete exam of visual system | 775 | $130 | $87 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 354 | $26 | $19 |
| J3590 | Unclassified biologics | 255 | $1,684 | $1,342 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | MD466188 | PA |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | MD466188 | PA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Pennsylvania
- NPI 1760786982
- NPI 1922056712
- NPI 1326212960
- NPI 1437156726
- NPI 1720138498
- NPI 1700850179
- NPI 1740248038
- NPI 1942274535
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.